• 2017 Marshall M. Parks Lecture

    Edwin M. Stone, MD, PhD, presents his 2017 Marshall M. Parks Lecture:Curing Heritable Blindness

    “If we are going to sustainably deliver gene- and stem-cell-based treatments to the tens of thousands of people who need them, we will need to be able to do it for well less than $50,000 per patient. In our cur­rent health care environment, the vast majority of people in the United States will not be able to afford treatments at the $1 million price point that many commercial entities are proposing. This presentation will summarize the science and the strategy behind a nonprofit effort to develop affordable gene- and cell-based treatments for all forms of inherited retinal disease.”—Dr. Stone

    Monday Nov. 13, 9:38-9:58 a.m., during Sym25, Genetic Disorders in Pediatric Ophthalmology, at AAO 2017.

    Where: Room 243.

    Genetic Disorders in Pediatric Ophthalmology (8:30-10:00 a.m.) is cosponsored by the American Association for Pediatric Ophthalmology and Strabismus. 

    This preview was excerpted from EyeNet AAO 2017 News, a tabloid distributed at the Morial Convention Center.